With Topical Vaccine, Bats May Be Able to Vaccinate Themselves Against Rabies
More than 1,300 species of bats roam the planet
Displaying 341 - 350 of 1680 results
Morris Animal Foundation Welcomes New Members to Board of Trustees
DENVER/August 12, 2015 – Morris Animal Foundation
Morris Animal Foundation Awards 17 Grants to Fund Diverse Set of Equine Health Studies
January 19, 2016 – Morris Animal Foundation funds 17 new large animal research and training grants totaling $1.1 million, from infectious disease to musculoskeletal disorders.
Morris Animal Foundation Launches $1.2 Million Initiative to Fight Deadly Disease of Cats
DENVER/Oct 14, 2015 – Morris Animal Foundation, a
Highly Contagious Infection Threatens Endangered San Joaquin Kit Fox Population
March 17, 2017 – Sarcoptic mange, a skin disease caused by mites, threatens endangered kit foxes.
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Testing Strategies to Treat Drug-Resistant Hemangiosarcomas
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
Assessing the NDY1 Protein as a Potential Treatment for Mast Cell Cancer
The goal of this study is to determine new strategies for treating canine mast cell tumors based on the targeting of a DNA-packaging protein called NDY1.
Developing a Way to Predict Length of Disease-Free Intervals for Dogs with Bone Cancer
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.
Determining How Overexpression of miR-9 Helps Osteosarcoma Spread
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.